Outbreak response intervention models of vaccine-preventable diseases in humans and foot-and- mouth disease in livestock : a protocol for a systematic review by Azam, James M. et al.
1Azam JM, et al. BMJ Open 2020;10:e036172. doi:10.1136/bmjopen-2019-036172
Open access 
Outbreak response intervention models 
of vaccine- preventable diseases in 
humans and foot- and- mouth disease in 
livestock: a protocol for a 
systematic review
James M Azam   ,1 Elisha B Are   ,1 Xiaoxi Pang,2 Matthew J Ferrari   ,3 
Juliet R C Pulliam   1
To cite: Azam JM, Are EB, 
Pang X, et al.  Outbreak 
response intervention models 
of vaccine- preventable 
diseases in humans and 
foot- and- mouth disease in 
livestock: a protocol for a 
systematic review. BMJ Open 
2020;10:e036172. doi:10.1136/
bmjopen-2019-036172
 ► Prepublication history and 
supplemental material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
036172).
Received 04 December 2019
Revised 31 July 2020
Accepted 26 August 2020
For numbered affiliations see 
end of article.
Correspondence to
James M Azam;  
 jamesazam@ sun. ac. za
Protocol
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Introduction Outbreaks of vaccine- preventable 
diseases continue to threaten public health, despite 
the proven effectiveness of vaccines. Interventions 
such as vaccination, social distancing and palliative 
care are usually implemented, either individually or in 
combination, to control these outbreaks. Mathematical 
models are often used to assess the impact of these 
interventions and for supporting outbreak response 
decision making. The objectives of this systematic 
review, which covers all human vaccine- preventable 
diseases, are to determine the relative impact of 
vaccination compared with other outbreak interventions, 
and to ascertain the temporal trends in the use of 
modelling in outbreak response decision making. We will 
also identify gaps and opportunities for future research 
through a comparison with the foot- and- mouth disease 
outbreak response modelling literature, which has good 
examples of the use of modelling to inform outbreak 
response intervention decision making.
Methods and analysis We searched on PubMed, 
Scopus, Web of Science, Google Scholar and some 
preprint servers from the start of indexing to 15 January 
2020. Inclusion: modelling studies, published in English, 
that use a mechanistic approach to evaluate the impact 
of an outbreak intervention. Exclusion: reviews, and 
studies that do not describe or use mechanistic models 
or do not describe an outbreak. We will extract data from 
the included studies such as their objectives, model 
types and composition, and conclusions on the impact 
of the intervention. We will ascertain the impact of 
models on outbreak response decision making through 
visualisation of time trends in the use of the models. We 
will also present our results in narrative style.
Ethics and dissemination This systematic review will not 
require any ethics approval since it only involves scientific 
articles. The review will be disseminated in a peer- reviewed 
journal and at various conferences fitting its scope.
PROSPERO registration number CRD42020160803.
INTRODUCTION
Great progress has been made globally in 
reducing the high rates of child mortality and 
morbidity attributed to vaccine- preventable 
diseases.1 However, outbreaks of these diseases 
continue to threaten global health and well- 
being. When these outbreaks occur, outbreak 
response interventions may be organised 
to control or halt disease spread. There are 
numerous interventions for preventing and 
controlling outbreaks of vaccine- preventable 
diseases. Immunisation is one of the most 
cost- effective.2 Additionally, a diversity of 
other interventions exist for complementing 
vaccination, but their implementation 
depends on the disease type, epidemic size, 
intervention timing and budget allocation.3 
For instance, during outbreaks of diseases 
like smallpox and Ebola, a combination of 
contact tracing, isolation, quarantine and 
vaccination have been employed to effectively 
control the pathogen.4–6 More generally, case 
Strengths and limitations of this study
 ► To the best of our knowledge, this is the first system-
atic review to examine studies that use mechanistic 
models to assess the relative benefit of vaccination 
compared with other outbreak interventions, and to 
ascertain the impact of modelling studies on policy 
making and decision making.
 ► The detailed search strategy used in this system-
atic review captures all human vaccine- preventable 
diseases.
 ► This review protocol is developed according to the 
Preferred Reporting of Items in Systematic Reviews 
and Meta- Analyses guidelines, hence, reported in a 
standard manner.
 ► This review will only consider studies published in 
English and may miss any studies written in other 
languages, but our initial search results show that 
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management and vaccination are used concurrently to 
reduce transmission and disease- related mortality during 
outbreaks of vaccine- preventable diseases.7
Outbreak response interventions have many public 
health and economic benefits. Vaccination particularly 
helps increase population- level immunity, preventing 
illness and death, and reduces productivity losses due 
to illness.8 For outbreaks of diseases like measles, whose 
control through vaccination is part of the routine 
immunisation schedule, outbreak response vaccination 
campaigns serve as an opportunity to immunise individ-
uals who were missed by routine vaccination.9
Mathematical models are useful for understanding 
many aspects of outbreaks.10–12 Particularly, outbreak 
response intervention models are an application of 
mathematical models for studying efficient ways of 
controlling outbreaks. They have three general applica-
tions, namely forecasting of epidemic spread, analysing 
of disease surveillance, and assessment of intervention 
impact.13 They are widely employed for investigating 
the potential impact of reactive interventions, identi-
fying and assessing strategies that help achieve efficient 
interventions, and considering future intervention deci-
sions.12 14 Over the past few decades, there has been a 
rise in the use of outbreak response intervention models 
for informing response strategies, decision making, and 
policy making.11 15 In fact, a recent theme issue by the 
Philosophical Transactions of the Royal Society acknowledged 
this rise in their use and highlighted some current model-
ling work with regard to our understanding and control 
of outbreaks of infectious diseases of humans, animals, 
and plants.13 However, we are unaware of any system-
atic review that has examined this increase in trend for 
all human vaccine- preventable diseases. Moreover, it is 
common for models to be described in the literature as 
being useful for informing outbreak response decision 
making,16 but to the best of our knowledge, no systematic 
review has evaluated the degree to which this assertion is 
true. Hence, an objective of this review will be to assess 
whether models are increasingly being used to inform 
outbreak response decision making and policy making.
It is clear in the outbreak response literature that a 
wealth of policy- relevant models have amassed from 
previous efforts to control outbreaks of foot- and- mouth 
disease (FMD).17–19 In fact, models of foot- and- mouth 
disease were the first to be used for outbreak response 
decision making.16 20 Additionally, FMD outbreak 
response models are well studied in epidemiological 
modelling and are often used to illustrate the usefulness 
of models in outbreak response decision making.21 We 
will, therefore, include eligible FMD modelling studies 
to help us to compare the current practice of outbreak 
response modelling for intervention impact assessment 
and decision making in the human vaccine- preventable 
diseases literature.
Several systematic reviews have been conducted to 
describe the use of models to assess the impact of inter-
ventions on outbreaks of infectious diseases and to 
ascertain their impact on policy making and decision 
making.20 22 However, these reviews are often focused on a 
few diseases. One systematic review, for instance, explored 
models that assessed the impact of future vaccines on 
tuberculosis (TB) infection.23 Additionally, few reviews 
have attempted to assess the conclusions of models on 
the relative benefit of vaccination compared with other 
outbreak interventions during outbreaks of human 
vaccine- preventable diseases. For example, a systematic 
review by Lee et al 24 compared the effectiveness of combi-
nation strategies with single strategies but the baseline 
intervention was not vaccination and the disease scope 
was pandemic influenza. Hence, this systematic review 
will identify the overall conclusion on the relative impact 
of vaccination compared with other outbreak interven-
tions, when models are used as the assessment tool. This 
systematic review will also highlight research gaps and 
opportunities for future research. The main objectives 
for this review are informed by that of a larger project, 
which involves the formulation and use of models to eval-
uate alternative intervention strategies for responding to 
measles outbreaks. This review will be useful to infectious 
disease modellers, both novice and expert, and policy 
makers who may already be using or considering the use 
of models for decision making.
Objectives
Our main objectives are:
1. To assess the relative impact of vaccination compared 
with other reactive interventions during outbreaks of 
human vaccine- preventable diseases.
2. To determine whether mathematical modelling is in-
creasingly impacting on the policy making and deci-
sion making process during outbreak response.
Additionally, our secondary objectives are:
1. To summarise similarities and differences in modelling 
approaches of included studies.
2. To identify knowledge gaps in modelling approaches 
and opportunities for advancement.
3. To identify and summarise parallels and contrasts be-
tween the outbreak response modelling literature for 
vaccine- preventable diseases in humans, and foot- and- 
mouth disease in livestock.
METHODS
In conducting this review, we will adhere to the criteria 
listed in the Preferred Reporting of Items in Systematic 
Reviews and Meta- Analyses statement.25 26 A supplemen-
tary file contains the populated checklist for the protocol 
(see online supplemental file 1).
For this systematic review, we will consider a model as 
mechanistic if it describes the disease’s individual- level or 
population- level transmission dynamics by capturing its 
biological mechanisms or natural history with some form 
of mathematical equation22 27. Consequently, we describe 
as outbreak response intervention models, all mecha-
nistic models that have been developed to investigate the 
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impact of any intervention to the outbreak of a vaccine- 
preventable disease affecting humans.
Patient and public involvement
This research will not require the involvement of patients 
as the review will involve the use of secondary informa-
tion collected from modelling studies.
Eligibility criteria
Here, we describe the criteria for article selection.
Type of studies
We will consider studies containing a mathematical 
model, which is mechanistic based on our earlier defini-
tion, and is used for assessing vaccination and/or other 
interventions mounted during an outbreak of any of 
the human vaccine- preventable diseases listed in table 1 
below. Table 1 contains WHO’s published list of human 
vaccine- preventable diseases.28 Even though Ebola is not 
on the list provided by WHO, we will include it in our 
search because there is a vaccine, which has been used for 
outbreak response in Central, East and West Africa29 and 
has been modelled in the literature.
We will limit the studies to those published in English. 
For the search period restriction, the beginning date 
limit will be based on how far back the database can be 
searched and the upper limit will be 15 January 2020.
Type of intervention
We will consider outbreak response vaccination and 
other outbreak interventions, that is, any responses 
mounted because of an outbreak, such as social/physical 
distancing, quarantine, isolation, palliative care, media 
coverage /information campaigns, education and others 
indicated in the articles.
Outcomes
The two main outcomes will be a conclusion on the 
temporal trends in the use of modelling as a decision- 
making tool during outbreak response of human 
vaccine- preventable diseases, and the overall conclusion 
on the relative benefit of vaccination and non- vaccination 
interventions mounted in response to outbreaks of 
human vaccine preventable diseases, with modelling 
as the tool of assessment. The secondary outcomes will 
include a summary of the outbreak response modelling 
landscape. We will obtain this in terms of the diseases 
and interventions studied, classes of models used, math-
ematical or statistical approaches for incorporating the 
intervention(s), and method used to analyse/evaluate 
the model and intervention. Other outcomes will be the 
types of equations used, the conclusions drawn from the 
models, study limitations stated and recommendations 
provided.
Information sources
We will search through the following sources:
1. Bibliographic databases: Scopus, PubMed and Web of 
Science.
2. Preprint:  bioRxiv. org, and  medRxiv. org.
3. Grey literature: Google Scholar.
Search strategy
With feedback from the Stellenbosch University Faculty 
of Science Librarian, we have developed search strings 
for the three bibliographic databases and Google Scholar. 
Details of the search strings can be found in the online 
supplemental file 2. To validate the search string, we used 
a list of known references from the literature and found 
that the strings capture all the relevant articles.
Preprint servers do not support Boolean searches, 
making it difficult to predefine the exact search proce-
dure. We will, therefore, hand search the preprint servers 
with keywords such as ‘outbreak response’, ‘model’, and 
their synonyms. The final procedure will be reported in 
the systematic review.
To identify relevant grey literature, we will search 
through Google Scholar, which supports Boolean 
searches, and websites of epidemic response organisa-
tions that are known (or likely) to use modelling in under-
standing outbreaks, for example, the Centers for Disease 
Control and Prevention. We will also contact authors 
from cited unpublished literature in the studies we will 
identify from the peer- reviewed and preprint literature.
STUDY RECORDS
Data management
The initial search results will be imported into EndNote 
X7.8 ( endnote. com) for deduplication. Following that, 
the Rayyan web tool30 will be used for the study selection. 
The KoboToolbox web tool (https://www. kobotoolbox. 
org/) will be used to extract the data from included 
studies. The extracted data will be exported in a comma- 
separated values format for further analyses. All postpro-
cessing of the exported data, including visualisations, will 
be performed with the R language.31
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Selection process
In the first stage, one reviewer will examine the preprints 
and grey literature search results to check whether any 
have been published as peer- reviewed articles. The 
reviewer will achieve this using the author names and 
working titles. If any of such exist, the reviewer will remove 
the preprint/grey literature version from the search 
results and record the number of removed records. If 
any uncertainties arise, the reviewer will consult the 
other reviewers. Following that, the reviewer will remove 
the duplicates from the total resulting records, using 
EndNote X7.8. With the aid of the Rayyan web tool the 
reviewers will screen the titles and abstracts, and if neces-
sary, full text of resulting articles in duplicate using the 
inclusion/exclusion criteria listed below.
Inclusion
1. Diseases are either listed in table 1, Ebola or foot- and- 
mouth disease.
2. Mathematical modelling studies.
3. The mathematical model is mechanistic, that is, its 
structure is represented with at least one mathematical 
equation informed by explicit assumptions about the 
natural history of the disease.22
4. The modelling study assesses the impact of an inter-
vention during an outbreak of one of the eligible dis-
eases.
5. The study is written in English.
Exclusion
1. Reviews, whether peer- reviewed or not.
2. Not a human vaccine- preventable disease listed in ta-
ble 1, Ebola or foot- and- mouth disease.
3. Not describing an outbreak.
4. Does not formulate or use a model.
5. Model is not mechanistic according to our definition 
above.
6. Not written in English.
7. Full- text unobtainable after contacting the school li-
brarian, and the corresponding author.
Data collection process
We will develop a data extraction form according to the 
items in online supplemental file 3. The reviewers will 
initially pilot the form with an article on each of the 
distinct diseases from the included articles to resolve any 
confusion. The pilot phase will help ensure we capture 
any form of non- standard practice across the various 
disease models. Following that, the reviewers will split the 
data collection task among themselves and work inde-
pendently. We will combine the resulting data after a set 
number of articles, and clarify any confusions further 
encountered, through discussion.
DATA ITEMS
Three reviewers will independently extract the data from 
their share of included articles according to the data items 
outlined in the online supplemental file 3 provided. If 
any disagreements arise from the data extraction process, 
we will resolve it through discussions with the other two 
reviewers.
QUALITY ASSESSMENT
It is not the objective of this systematic review to assess 
the quality of the included models or to select a best or 
worst model or model design. We will, therefore, not be 
assessing the quality of the included modelling studies.
DATA
Synthesis
We will report in a narrative style, comparing groups of 
articles sharing common approaches and themes. The 
themes will include diseases modelled, classes of models, 
categories of objectives, and so forth. For example, we 
will compare which articles employed deterministic 
models vs stochastic models. These groupings will also be 
summarised in a citation table. In addition, we will study 
the included studies from the outbreak response model-
ling literature for foot- and- mouth disease in livestock, 
and the human vaccine- preventable disease outbreak 
modelling literature to highlight their commonalities 
and differences in approach, objectives, and so on. This 
will help highlight any gaps and opportunities as well 
as recommendations we will provide as an outcome of 
this review for the human vaccine- preventable disease 
outbreak response modelling community.
ETHICS AND DISSEMINATION
This study does not require any ethics approval as we 
will not be collecting any primary data. We will dissem-
inate our results through a peer- reviewed journal and 
conferences.
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